Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer
Open Access
- 15 July 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 111 (4), 726-735
- https://doi.org/10.1038/bjc.2014.377
Abstract
Background: Over the past years, some members of the family of suppressor of cytokine signalling (SOCS) proteins have emerged as potential tumour suppressors. This study aimed at investigating the clinical significance of SOCS proteins in colorectal carcinoma (CRC). Methods: We integrated publicly available microarray expression data on CRC in humans, analysed the expression pattern of SOCSs and assessed the predictive power of SOCS2 and SOCS6 for diagnostic purposes by generating receiver operating characteristic curves. Using laser microdissected patient material we assessed SOCS expression on RNA and protein levels as well as their methylation status in an independent CRC patient cohort. Finally, we investigated the prognostic value of SOCS2 and SOCS6. Results: The meta-analysis as well as the independent patient cohort analysis reveal a stage-independent downregulation of SOCS2 and SOCS6 and identify both molecules as diagnostic biomarkers for CRC. We demonstrate a different methylation pattern within the SOCS2 promoter between tumour tissue and normal control tissue in 25% of CRC patients. Furthermore, early CRC stage patients with low expression of SOCS2 display significantly shorter disease-free survival. Conclusions: Our data offers evidence that SOCS2 and SOCS6 levels are reduced in CRC and may serve as diagnostic biomarkers for CRC patients.Keywords
This publication has 55 references indexed in Scilit:
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic ValuePLoS Medicine, 2013
- Comprehensive meta-analysis of Signal Transducers and Activators of Transcription (STAT) genomic binding patterns discerns cell-specific cis-regulatory modulesBMC Genomics, 2013
- Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer developmentMolecular and Cellular Endocrinology, 2012
- Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancerBMC Cancer, 2010
- Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon CancerGastroenterology, 2010
- Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitorBritish Journal of Cancer, 2010
- Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal CancerClinical Cancer Research, 2009
- Quantitative RT-PCR gene expression analysis of laser microdissected tissue samplesNature Protocols, 2009
- Transcriptome Profile of Human Colorectal AdenomasMolecular Cancer Research, 2007
- Favorable prognostic value of SOCS2 and IGF-I in breast cancerBMC Cancer, 2007